Association between p53 codon 72 polymorphism and cervical cancer risk among asians: A huge review and meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 4909-4914

  Zhou, Xin ^a   Gu, Yang ^a   Zhang, Shu Lan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Asian; Cervical cancer; Meta analysis; P53 gene; Polymorphism; Susceptibility

Indexed keywords

EID: 84874017325     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.4909     Document Type: Article

References (51)

1. Ashton KA, Proietto A, Otton G, et al (2009). Polymorphisms in TP53 and MDM2 combined are associated with high grade endometrial cancer. Gynecol Oncol, 113, 109-14.
2. Baek WK, Cho JW, Suh SI, et al (2000). p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women. J Korean Med Sci, 15, 65-7.
3. Berchuck A, Kohler MF, Marks JR, et al (1994). The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol, 170, 246-52.
4. Bhattacharya P, Duttagupta C, Sengupta S (2002). Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Lett, 188, 207-11.
5. Cho NH, Lim SY, Kim YT, et al (2003). G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value. Gynecol Oncol, 90, 15-22.
6. Fan R, Wu MT, Miller D, et al (2000). The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 1037-42.
7. Grochola LF, Zeron-Medina J, Meriaux S, et al (2010). Single-nucleotide polymorphisms in the p53 signaling pathway. Cold Spring Harb Perspect Biol, 2, a001032.
8. Harris CC, Hollstein M (1993). Clinical implications of the p53 tumor-suppressor gene. N Engl J Med, 329, 1318-27.
9. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
10. Hou MM, Xi MR, Cao ZY, et al (2006). P53 codon 72 polymorphism in cervical cancers and its correlation with HPV16,18E6. Sichuan Da Xue Xue Bao Yi Xue Ban, 37, 404-7.
11. Jemal A, Siegel R, Xu J, et al (2010). Cancer statistics, 2010. CA Cancer J Clin, 60, 277-300.
12. Katiyar S, Thelma BK, Murthy NS, et al (2003). Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem, 252, 117-24.
13. Kawamata Y, Mitsuhashi A, Unno Y, et al (2002). HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes. Int J Oncol, 21, 561-7.
14. Kim JW, Lee CG, Park YG, et al (2000). Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer, 88, 2082-91.
15. Kim JW, Roh JW, Park NH, et al (2001). Polymorphism of TP53 codon 72 and the risk of cervical cancer among Korean women. Am J Obstet Gynecol, 184, 55-8.
16. Koushik A, Platt RW, Franco EL (2004). p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev, 13, 11-22.
17. Lax SF (2004). Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification. Virchows Arch, 444, 213-23.
18. Lee JE, Lee SJ, Namkoong SE, et al (2004). Gene-gene and gene-environmental interactions of p53, p21, and IRF-1 polymorphisms in Korean women with cervix cancer. Int J Gynecol Cancer, 14, 118-25.
19. Li CY, Liu JH, Huang BJ (2004). Correlation between P53 codon 72 polymorphism and tumorigenesis of cervical cancer. Ai Zheng, 23, 1396-9.
20. Minaguchi T, Kanamori Y, Matsushima M, et al (1998). No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res, 58, 4585-6.
21. Mitra S, Misra C, Singh RK, et al (2005). Association of specific genotype and haplotype of p53 gene with cervical cancer in India. J Clin Pathol, 58, 26-31.
22. Nagpal JK, Sahni S, Das BR (2002). P53 codon 72 polymorphism and susceptibility to development of human papilloma virus-associated cervical cancer in Indian women. Eur J ClinInvest, 32, 943-8.
23. Ngan HY, Liu VW, Liu SS (1999). Risk of cervical cancer is not increased in Chinese carrying homozygous arginine at codon 72 of p53. Br J Cancer, 80, 1828-9.
24. Niwa Y, Hamajima N, Atsuta Y, et al (2004). Genetic polymorphisms of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro and the risk of cervical cancer in Japanese. Cancer Lett, 205, 55-60.
25. Nunobiki O, Ueda M, Yamamoto M, et al (2009). Polymorphisms of p53 codon 72 and MDM2 promoter 309 and the risk of endometrial cancer. Hum Cell, 22, 101-6.
26. Ozalp S, Yalcin OT, Tanir HM, et al (2003). p53 overexpression as a prognostic indicator in endometrial carcinoma. Eur J Gynaecol Oncol, 24, 275-8.
27. Pecorelli S, Favalli G, Zigliani L, et al (2003). Cancer in women. Int J Gynaecol Obstet, 82, 369-79.
28. Peters JL, Sutton AJ, Jones DR, et al (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295, 676-80.
29. Qie M, Zhang Y and Wu J (2002). Study on the relationship between cervical cancer and p53 codon 72 polymorphism. Hua Xi Yi Ke Da Xue Xue Bao, 33, 274-5.
30. Risinger JI, Dent GA, Ignar-Trowbridge D, et al (1992). p53 gene mutations in human endometrial carcinoma. Mol Carcinog, 5, 250-3.
31. Roh JW, Kim JW, Park NH, et al (2004). p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Gynecol Oncol, 93, 499-505.
32. Saranath D, Khan Z, Tandle AT, et al (2002). HPV16/18 prevalence in cervical lesions/cancers and p53 genotypes in cervical cancer patients from India. Gynecol Oncol, 86, 157-62.
33. Settheetham-Ishida W, Singto Y, Yuenyao P, et al (2004). Contribution of epigenetic risk factors but not p53 condon72 polymorphism to the development of cervical cancer in Northeastern Thailand. Cancer Lett, 2, 205-11.
34. Sherman ME (2000). Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol, 13, 295-308.
35. Soliman PT, Oh JC, Schmeler KM, et al (2005). Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol, 105, 575-80.
36. Ueda M, Terai Y, Kanda K, et al (2006). Germline polymorphism of p53 codon 72 in gynecological cancer. Gynecol Oncol, 100, 173-8.
37. Wang XL, Pan XL, Zheng XZ, et al (2004). Correlation between P53 Condon72 polymorphism and cervical carcinoma among Uigur and Han People. J Shihezi University, 4, 340-4.
38. Whibley C, Pharoah PD and Hollstein M (2009). p53 polymorphisms: cancer implications. Nat Rev Cancer, 9, 95-107.
39. Wu MT, Liu CL, Ho CK, et al (2004). Genetic polymorphism of p53 and XRCC1 in cervical intraepithelial neoplasm in Taiwanese women. J Formos Med Assoc, 103, 337-43.
40. Yamashita T, Yaginuma Y, Saitoh Y, et al (1999). Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. Carcinogenesis, 20, 1733-6.
41. Yang A, Zheng X, Tao L, et al (2008). Studies on correlation between p21Ser31Arg, p53arg72Pro polymorphisms and cervical carcinoma in Uigur women in Xinjiang. J Shihezi University, 1, 6-11.
42. Yang HP, Gonzalez Bosquet J, Li Q, et al (2010). Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis, 31, 827-33.
43. Yang YC, Chang CL, Chen ML (2001). Effect of p53 polymorphism on the susceptibility of cervical cancer. Gynecol Obstet Invest, 51, 197-201.
44. Yao N, Zeng H, Lu J (2008). Correlation between p53 condon72 polymorphism and cervical cancer. Acta Academiae Zunyi, 1, 3-5.
45. Ye S (2000). Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol, 19, 623-9.
46. Zheng XZ, Yang AQ, Pan XL, et al (2008). Ethnicity determines association of p53Arg72Pro alleles with cervical cancer in China. Eur J Cancer Prev, 17, 460-6.
47. Zheng XZ, Yang AQ, Pan XL, et al (2007). Relationship between p53 Arg72Pro polymorphism and cervical carcinoma in Uigur and Han women in Xinjiang. Zhonghua Bing Li Xue Za Zhi, 36, 511-5.
48. Zhou X, Han S, Wang S, et al (2009). Polymorphisms in HPV E6/E7 protein interacted genes and risk of cervical cancer in Chinese women: a case-control analysis. Gynecol Oncol, 114, 327-31.
49. Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol, 28, 123-37.
50. Zubor P, Stanclova A, Kajo K, et al (2009). The p53 codon 72 exon 4 BstUI polymorphism and endometrial cancer in Caucasian women. Oncology, 76, 173-83.
51. Zucchetto A, Serraino D, Polesel J, et al (2009). Hormone-related factors and gynecological conditions in relation to endometrial cancer risk. Eur J Cancer Prev, 18, 316-21.